147 related articles for article (PubMed ID: 35903011)
21. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
[TBL] [Abstract][Full Text] [Related]
22. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
[TBL] [Abstract][Full Text] [Related]
23. Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis.
Salkind AR; Cuddy PG; Foxworth JW
Ann Pharmacother; 2002 Dec; 36(12):1938-43. PubMed ID: 12452758
[TBL] [Abstract][Full Text] [Related]
24. Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?
Ludlam HA; Enoch DA
Int J Antimicrob Agents; 2008 Aug; 32(2):101-5. PubMed ID: 18571380
[TBL] [Abstract][Full Text] [Related]
25. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.
Asadi L; Sligl WI; Eurich DT; Colmers IN; Tjosvold L; Marrie TJ; Majumdar SR
Clin Infect Dis; 2012 Aug; 55(3):371-80. PubMed ID: 22511553
[TBL] [Abstract][Full Text] [Related]
26. Antibiotics for ventilator-associated pneumonia.
Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
28. Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia.
Mokabberi R; Haftbaradaran A; Ravakhah K
J Clin Pharm Ther; 2010 Apr; 35(2):195-200. PubMed ID: 20456738
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroids for pneumonia.
Stern A; Skalsky K; Avni T; Carrara E; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007720. PubMed ID: 29236286
[TBL] [Abstract][Full Text] [Related]
30. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Sokol WN; Sullivan JG; Acampora MD; Busman TA; Notario GF
Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
[TBL] [Abstract][Full Text] [Related]
31. A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Gotfried MH; Dattani D; Riffer E; Devcich KJ; Busman TA; Notario GF; Palmer RN
Clin Ther; 2002 May; 24(5):736-51. PubMed ID: 12075942
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis.
Maimon N; Nopmaneejumruslers C; Marras TK
Eur Respir J; 2008 May; 31(5):1068-76. PubMed ID: 18216053
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
35. Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients.
Aldhahri RK; Gabb SG; Shoaib OA; Almadani RM; Eljaaly K; Thabit AK
Eur J Med Res; 2022 Dec; 27(1):279. PubMed ID: 36482485
[TBL] [Abstract][Full Text] [Related]
36. Mefloquine for preventing malaria during travel to endemic areas.
Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
[TBL] [Abstract][Full Text] [Related]
37. Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis.
Liu S; Tong X; Ma Y; Wang D; Huang J; Zhang L; Wu M; Wang L; Liu T; Fan H
Front Pharmacol; 2019; 10():489. PubMed ID: 31139081
[No Abstract] [Full Text] [Related]
38. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis.
Nie W; Li B; Xiu Q
J Antimicrob Chemother; 2014 Jun; 69(6):1441-6. PubMed ID: 24535276
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
40. Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalization.
Corrêa JC; Badaró R; Bumroongkit C; Mera JR; Dolmann AL; Juárez Martínez LG; Mayrinck LR; Tamez R; Yang JY
Clin Ther; 2003 May; 25(5):1453-68. PubMed ID: 12867221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
